AsOf

Novartis · operating income17,644,000,000 United States dollar

valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted

What the statuses mean

Valid from
2025-12-31
Valid until
still holds
Published
2026-02-04
Recorded by AsOf
2026-11-08
Checked
2026-11-08 · parsed from the SEC filing
Confidence
0.95

Sources

Cite this claim

Each form names the value, its as-of date (2025-12-31), the day you read it (2026-11-08), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "Novartis operating income: 17,644,000,000 United States dollar", as of 2025-12-31. Claim clm_13AEEBEB19A6, https://asof.is/claim/clm_13AEEBEB19A6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.
APA
AsOf. (2025). Novartis operating income: 17,644,000,000 United States dollar (as of 2025-12-31) [Record clm_13AEEBEB19A6]. Retrieved November 8, 2026, from https://asof.is/claim/clm_13AEEBEB19A6 (source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm)
BibTeX
@misc{asof_clm_13AEEBEB19A6,
  author = {AsOf},
  title = {Novartis operating income: 17,644,000,000 United States dollar},
  year = {2025},
  howpublished = {\url{https://asof.is/claim/clm_13AEEBEB19A6}},
  note = {Claim clm\_13AEEBEB19A6, as of 2025-12-31; source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm},
  urldate = {2026-11-08}
}

Supersedes

On the record

/claim/clm_13AEEBEB19A6.md/v1/claims/clm_13AEEBEB19A6submit a correction